PMPRB releases analytic study of Canadian oncology market

Smart & Biggar

On October 27, 2020, the Patented Medicine Prices Review Board (PMPRB) released the National Drug Prescription Utilization System’s (NDPUIS) analytic study of the Canadian oncology market for 2010 to 2019. The study is divided into three sections, first exploring the dynamics of the international market for oncology medicines, next reviewing oncology sales, distribution, and treatment costs in Canada, and finally examining these trends in the context of private drug plans.

The study concluded that:

  • Sales of oncology medicines in Canada have tripled over the past decade;
  • Per capita oncology sales in Canada remained below most comparator countries in 2019;
  • Since 2010, the share of oncology medicines as a proportion of the total Canadian market has more than doubled;
  • Recent trends show a greater international alignment in the prices of oncology medicines;
  • Over the last decade, the Canadian oncology market has shifted significantly towards higher-cost drugs;
  • The Canadian oncology market is largely driven by new medicines;
  • Canadian availability for top-selling new oncology medicines is in line with comparator countries; and
  • High-cost oncology medicines account for a growing share of drug costs in Canada’s private drug plans.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Smart & Biggar | Attorney Advertising

Written by:

Smart & Biggar

Smart & Biggar on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.